Just read this garbage they post about noronha, the quote unquote "chief scientific officer"
The below bio was taken from the clearside website sept 30, 2018
His track record is a joke, previous posts outlined the fiasco at Targegen where they burned Sanofi and his being drummed out of a device company prior and then what.....
a couple years at Alcon
a year at a place called sucampo
Then a few years at this clearside place
This is tantamount to wirefraud against investors, this guy isn't qualified to lead any scientific effort. Could you get a job with a resume like that!?! a year here, a couple years there all over the place. The truth is Clearside is a pump and dump just take a look at how many executives they have feeding at the trough, and all for what? There's hardly anything going on at this place.
This is his "bio" from Sept 30, 2018....these people have no shame, they think investors are morons obviously.....
Dr. Noronha was promoted to Chief Scientific Officer in August 2016 after having served as our Executive Vice President, Research and Development since August 2013. Dr. Noronha plays a critical role in all strategic, developmental and regulatory efforts at Clearside. From 2012 to 2013, he served as Vice President, Research and Development, at Sucampo Pharma Americas, LLC. From 2011 to 2012, Dr. Noronha was Chief Scientific Officer for JW Theriac, Inc., a pharmaceutical company focused on new drug research and development in oncology. From 2008 to 2011, Dr. Noronha was Global Project Lead for developmental efforts in retinal diseases at Alcon Laboratories, Inc., a Novartis company. From 2002 to 2008, Dr. Noronha held several positions with increasing levels of leadership and responsibility at TargeGen, Inc., a pharmaceutical company, including as co-lead for its ophthalmology programs. Dr. Noronha received his education and training in Chicago and Irvine.
